Literature DB >> 2615917

The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice.

J A Hoskins1, L J Davis.   

Abstract

The neurotoxic agent MPTP produces profound and sustained changes in the biochemistry of the brain in mice after a single dose of 20 mg/kg. Acute neurochemical changes have been examined in detail in 8 strains of mice. Coloured mice were more intoxicated than white mice when treated with MPTP: white mice were little affected behaviourally by a dose that could kill a sensitive coloured strain. Although changes in levels of dopamine were a good indication of the effect of treatment--particularly in the dopaminergic areas, the best discriminator between strains was changes in the levels of adrenaline and noradrenaline. Changes in levels of dopamine, which generally decreased in coloured mice, were not good indicators of toxicity. The changes in levels of adrenaline and noradrenaline discriminated better between strains: they were usually decreased in coloured mice but could substantially increase in white strains, particularly in certain areas of the brain. This study showed that there is a very considerable genetic component to the acute toxicity of MPTP within a single species. Even very closely related mice reacted quite differently to the effect. Also, it showed that white mice, in particular those from the commonly used BALB/c strain, are a poor model for any study of the toxicity of MPTP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615917     DOI: 10.1016/0028-3908(89)90015-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency.

Authors:  T Sengupta; J Vinayagam; N Nagashayana; B Gowda; P Jaisankar; K P Mohanakumar
Journal:  Neurochem Res       Date:  2010-10-23       Impact factor: 3.996

2.  Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.

Authors:  Justin D Boyd; Haeman Jang; Kennie R Shepherd; Ciaran Faherty; Sally Slack; Yun Jiao; Richard J Smeyne
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

Review 3.  MPTP mouse models of Parkinson's disease: an update.

Authors:  Gloria E Meredith; David J Rademacher
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

4.  Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism.

Authors:  Hannah V Oakes; David McWethy; Shannon Ketchem; Lily Tran; Kaitlyn Phillips; Laura Oakley; Richard J Smeyne; Brooks B Pond
Journal:  Neurotox Res       Date:  2021-03-05       Impact factor: 3.911

5.  Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease.

Authors:  R K Schwarting; M Sedelis; K Hofele; G W Auburger; J P Huston
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

Review 6.  Genetic factors in neurotoxicology and neuropharmacology: a critical evaluation of the use of genetics as a research tool.

Authors:  M F Festing
Journal:  Experientia       Date:  1991-10-15

7.  Chromosomal loci influencing the susceptibility to the parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  Marco Sedelis; Katja Hofele; Rainer K W Schwarting; Joseph P Huston; John K Belknap
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

8.  Differential response of C57BL/6J mouse and DBA/2J mouse to optic nerve crush.

Authors:  Justin P Templeton; Mohamed Nassr; Felix Vazquez-Chona; Natalie E Freeman-Anderson; William E Orr; Robert W Williams; Eldon E Geisert
Journal:  BMC Neurosci       Date:  2009-07-30       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.